Influenza Vaccine(Split Virion), Inactivated, Quadrivalent (ZFA02 Adjuvant,Anhui Zhifei Longcom Biologic Pharmacy)

四价流感病毒裂解疫苗（ZFA02佐剂，智飞龙科马生物制药）

Report date: 2025/02/01 20:00:06

Base Information

Drug NameInfluenza Vaccine(Split Virion), Inactivated, Quadrivalent (ZFA02 Adjuvant,Anhui Zhifei Longcom Biologic Pharmacy)
Drug Alias NameN/A
ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Inactivated vaccine > Split vaccineVaccines > Biological material > Viral vaccine +[4] 
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A